Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03033056 · ClinicalTrials.gov registry record
Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 208
- Enrollment target
NCT03033056 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 208 participants.
The verdict
NCT03033056 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
Anxiety disorders are among the most prevalent, costly, and disabling mental illnesses. One central, yet largely understudied, abnormality in anxiety disorders is the heightened tendency to display fear and avoidance in reaction to benign or safe events that resemble feared situations. The current project maps brain circuits associated with this abnormality in order to contribute to future brain-based diagnosis and treatments for clinical anxiety.
Interventions
- BEHAVIORAL Test of fear conditioning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2021-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03033056
The ClinicalTrials.gov registry entry for NCT03033056 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Test of fear conditioning is the first listed.
NCT03033056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03033056 about?
NCT03033056 is a clinical study titled "Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders". Anxiety disorders are among the most prevalent, costly, and disabling mental illnesses. One central, yet largely understudied, abnormality in anxiety disorders is the heightened tendency to display fear and avoidance in reaction to benign or safe events that resemble feared situations. The current p...
What is the current status of trial NCT03033056?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2017-07-17. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT03033056?
The interventions under investigation include: Test of fear conditioning (BEHAVIORAL).
Who is sponsoring clinical trial NCT03033056?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.